ATE126702T1 - Verfahren zur herstellung von impfstoffen gegen rna-virus. - Google Patents

Verfahren zur herstellung von impfstoffen gegen rna-virus.

Info

Publication number: ATE126702T1
Authority: AT; Austria
Prior art keywords: cells; rna virus; virus; vaccines against; against rna
Prior art date: 1989-06-14

Application number

AT90909343T

Other languages

English (en)

Inventor

Gordon Robert Bruce Ha Skinner

Alexander Buchan

Original Assignee

Univ Birmingham

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-14

Filing date

1990-06-12

Publication date

1995-09-15

1990-06-12 Application filed by Univ Birmingham filed Critical Univ Birmingham

1995-09-15 Application granted granted Critical

1995-09-15 Publication of ATE126702T1 publication Critical patent/ATE126702T1/de

Links

229960005486 vaccine Drugs 0.000 title abstract 3
241000700605 Viruses Species 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
230000001086 cytosolic effect Effects 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
241000709664 Picornaviridae Species 0.000 abstract 1
230000000890 antigenic effect Effects 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
230000009089 cytolysis Effects 0.000 abstract 1
241001493065 dsRNA viruses Species 0.000 abstract 1
230000000087 stabilizing effect Effects 0.000 abstract 1
241001430294 unidentified retrovirus Species 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

AT90909343T 1989-06-14 1990-06-12 Verfahren zur herstellung von impfstoffen gegen rna-virus. ATE126702T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898913665A GB8913665D0 (en)	1989-06-14	1989-06-14	Method of preparing vaccines against rna viruses

Publications (1)

Publication Number	Publication Date
ATE126702T1 true ATE126702T1 (de)	1995-09-15

Family

ID=10658419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90909343T ATE126702T1 (de)	1989-06-14	1990-06-12	Verfahren zur herstellung von impfstoffen gegen rna-virus.

Country Status (8)

Country	Link
EP (1)	EP0477240B1 (de)
JP (1)	JP2973372B2 (de)
AT (1)	ATE126702T1 (de)
AU (1)	AU637114B2 (de)
CA (1)	CA2060198C (de)
DE (1)	DE69021879T2 (de)
GB (1)	GB8913665D0 (de)
WO (1)	WO1990015622A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1267591A (en) *	1969-02-26	1972-03-22	Nat Res Dev	Antigenic materials
DE3378611D1 (en) *	1982-03-24	1989-01-12	Univ Birmingham	Vaccine against dna viruses
NZ225583A (en) *	1987-08-06	1991-07-26	Merck & Co Inc	Process for purifying hepatitis a virions (hav)

1989
- 1989-06-14 GB GB898913665A patent/GB8913665D0/en active Pending
1990
- 1990-06-12 JP JP2508641A patent/JP2973372B2/ja not_active Expired - Fee Related
- 1990-06-12 DE DE69021879T patent/DE69021879T2/de not_active Expired - Fee Related
- 1990-06-12 WO PCT/GB1990/000905 patent/WO1990015622A1/en not_active Ceased
- 1990-06-12 EP EP90909343A patent/EP0477240B1/de not_active Expired - Lifetime
- 1990-06-12 AT AT90909343T patent/ATE126702T1/de not_active IP Right Cessation
- 1990-06-12 AU AU58326/90A patent/AU637114B2/en not_active Ceased
- 1990-06-12 CA CA002060198A patent/CA2060198C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69021879T2 (de)	1996-04-04
EP0477240A1 (de)	1992-04-01
AU5832690A (en)	1991-01-08
DE69021879D1 (de)	1995-09-28
GB8913665D0 (en)	1989-08-02
JP2973372B2 (ja)	1999-11-08
AU637114B2 (en)	1993-05-20
CA2060198C (en)	2000-05-02
CA2060198A1 (en)	1990-12-15
JPH04506209A (ja)	1992-10-29
EP0477240B1 (de)	1995-08-23
WO1990015622A1 (en)	1990-12-27

Similar Documents

Publication	Publication Date	Title
BR9712592A (pt)	1999-12-21	Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
FI932678A0 (fi)	1993-06-11	Pao alfavirus baserande DNA expressionssystem
DE69333814D1 (de)	2005-06-23	Genetischer impfstoff gegen den immunschwäche virus
ATE429246T1 (de)	2009-05-15	Verfahren zur herstellung von biologischen produkten in protein-freiem kultur
CY1110359T1 (el)	2015-04-29	Εμβολια με βαση σιρκοϊους χοιρων
AU2684792A (en)	1993-05-21	Porcine reproductive respiratory syndrome vaccine and diagnostic
ATE140031T1 (de)	1996-07-15	Rekombinante poxvirusinnenkerne
EE200300331A (et)	2003-10-15	Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarüootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin
ATE420189T1 (de)	2009-01-15	Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus
SE8701413D0 (sv)	1987-04-03	Expression and purification of an htlv-iii gag/env gene protein
BR0016145A (pt)	2002-08-13	Clones infecciosos
DE68915165D1 (de)	1994-06-09	Schimärische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DE3775321D1 (de)	1992-01-30	Verfahren zur kultur des virus der rhinotracheitis des truthahnes und daraus hergestelltes vakzin.
TW377373B (en)	1999-12-21	Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
DK157186A (da)	1986-10-09	Ekspression af immunologisk aktive virale proteiner
ATE365206T1 (de)	2007-07-15	Verfahren zur entwicklung von einem hiv impfstoff
DE3689622D1 (de)	1994-03-17	Impfstoffe gegen menschliche respiratorische viren.
SE9903031D0 (sv)	1999-08-27	Peptide mixture and vaccine against a chronic viral infection
EP0236977A3 (de)	1989-05-03	Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera
ATE126702T1 (de)	1995-09-15	Verfahren zur herstellung von impfstoffen gegen rna-virus.
DE69633919D1 (de)	2004-12-30	Mehrzweckvakzine gegen umhüllte viren
BRPI0209416A8 (pt)	2018-05-08	novos vetores de expressão e uso dos mesmos
FI923020A0 (fi)	1992-06-29	Inte a inte b-sekvenser.
RU98116217A (ru)	2000-07-20	Способ получения белка с использованием трансляционной системы митохондрий
WO1997027742B1 (en)	1997-09-25	Method of protein production using mitochondrial translation system

Legal Events

Date	Code	Title	Description
1996-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties